SCHEMBL16023776

SCHEMBL16023776

Cc1coc2c1C(=O)C(=O)c1c-2ccc2c1CCC(C)(C)C2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EED O75530 5/20 0.65
▸ SUZ12 Q15022 5/20 0.65
▸ EZH2 Q15910 5/20 0.65
▸ CES1 P23141 4/20 0.65
▸ HIF1A Q16665 2/20 0.65
▸ EPAS1 Q99814 2/20 0.65
▸ KDM4E B2RXH2 1/20 0.65
▸ MEN1 O00255 1/20 0.65
▸ CES2 O00748 1/20 0.65
▸ APAF1 O14727 1/20 0.65
▸ TERT O14746 1/20 0.65
▸ ALDH1A1 P00352 1/20 0.65
▸ LMNA P02545 1/20 0.65
▸ TP53 P04637 1/20 0.65
▸ POLB P06746 1/20 0.65
▸ MAPT P10636 1/20 0.65
▸ AKR1B1 P15121 1/20 0.65
▸ HPGD P15428 1/20 0.65
▸ ALOX12 P18054 1/20 0.65
▸ APEX1 P27695 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16023774 0.81 EED (0.66) EEDSUZ12EZH2CES1HIF1A
Tanshinone Iia SCHEMBL2026738 0.79 EED (1.00) EEDSUZ12EZH2CES1HIF1A
SCHEMBL16152326 0.77 EED (0.78) EEDSUZ12EZH2CES1HIF1A
SCHEMBL16023779 0.75 IDO1 (0.60) EEDSUZ12EZH2CES1HIF1A
Tanshinone Iib SCHEMBL14417728 0.74 EED (1.00) EEDSUZ12EZH2CES1HIF1A
Tanshinone Iib SCHEMBL11945767 0.74 EED (1.00) EEDSUZ12EZH2CES1HIF1A
SCHEMBL16152317 0.73 EED (0.62) EEDSUZ12EZH2CES1HIF1A
SCHEMBL16023775 0.72 IDO1 (0.57) EEDSUZ12EZH2CES1HIF1A
SCHEMBL30923422 0.72 IDO1 (1.00) EEDSUZ12EZH2CES1HIF1A
Methyl Tanshinonate SCHEMBL14417730 0.72 EED (1.00) EEDSUZ12EZH2CES1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160022625-A1 TASHINONES AND THEIR DERIVATIVES: NOVEL EXCELLENT DRUGS FOR ALZHEIMER DISEASE THE UNIVERSITY OF AKRON 2016-01-28 — — US disclosed
US-20160022625-A1 TASHINONES AND THEIR DERIVATIVES: NOVEL EXCELLENT DRUGS FOR ALZHEIMER DISEASE THE UNIVERSITY OF AKRON 2016-01-28 — — US disclosed
WO-2014138357-A1 NOVEL TASHINONE DRUGS FOR ALZHEIMER DISEASE THE UNIVERSITY OF AKRON (US) 2014-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022625-A1 TASHINONES AND THEIR DERIVATIVES: NOVEL EXCELLENT DRUGS FOR ALZHEIMER DISEASE APP, HTT, PSEN1 EED 4772/4885SUZ12 4771/4885EZH2 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback